Call Today: 800-889-3898
Submit your Chantix claim details for a free, no obligation case review
Get Started:
Stevens Johnson Syndrome has been reported in patients after taking Pfizer’s smoking-cessation medication, Chantix. Stevens Johnson Syndrome is an immune-complex-mediated disease that affects a person’s skin and mucous membranes.
Although the syndrome was discovered in 1922, Stevens Johnson Syndrome’s link to Chantix has been in the news only since 2007 — not long after the late-2006 introduction of Chantix on the U.S. market.
The early signs reported in people taking Chantix that match Stevens Johnson Syndrome symptoms are:
When the Stevens Johnson Syndrome progresses, inflammation develops and blisters form at sites such as the:
The individual’s mucous membrane at these sites become inflamed, and a rapidly growing rash appears, often with flat and irregular lesions. The rash may appear first on the face and/or the trunk of the body, and then spread to the rest of the body. The rash can turn into blisters. Blisters around the eyes, genitals, and other areas of the body can be extremely painful.
Stevens Johnson Syndrome (SJS) can severely disable a healthy individual. It can even be fatal. It also occurs twice as often in females as in males; women are more prone to auto-immune diseases. Such an awful disease is never expected as an outcome of a smoking-cessation treatment.
Learn More about Chantix and Stevens Johnson Syndrome
If you were treated with Chantix and Stevens Johnson Syndrome signs or symptoms have developed, talk to an attorney who represents the victims of dangerous drugs. You may be entitled to compensation for your damages.
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice